Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
27-30 April, 2026
Not Confirmed
Not Confirmed
27-30 April, 2026
Bioprocess Internation...Bioprocess International Europe
Not Confirmed
Not Confirmed
27-30 April, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS







Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
27-30 April, 2026
Industry Trade Show
Not Confirmed
27-30 April, 2026
Bioprocess Internation...Bioprocess International Europe
Industry Trade Show
Not Confirmed
27-30 April, 2026
Digital content

29 Jun 2020
// PRNEWSWIRE
https://www.prnewswire.com/in/news-releases/revimmune-announces-phase-ii-trial-of-the-t-cell-growth-factor-cyt107-for-covid-19-823203358.html
ABOUT THIS PAGE
REVIMMUNE INC is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find CYT107 bulk offered by REVIMMUNE INC